Geoffrey Beran Rose
Equibles does not estimate personal net worth.
Get an email with a short summary when Pulmonx Corp publishes a filing, an earnings call transcript or a press release.
Get LUNG alertsAbout Geoffrey Beran Rose
The proxy statement of Pulmonx Corp reports total compensation of $1,957,816 for Geoffrey Beran Rose in fiscal 2023, including a base salary of $430,000. Disclosed compensation is on record for 5 fiscal years. Pulmonx Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Pulmonx Corp includes Glendon E. French (CEO and Board Member), Glendon French (CEO and Board Member), Steven S. Williamson (CEO and Board Member) and 5 others.
Affiliation history
-
Pulmonx Corp (LUNG)
Proxy statement
CurrentStart not stated–present
Last confirmed April 22, 2026
Company network
Leadership on record at Pulmonx Corp
- Glendon E. French CEO, Board Member
- Glendon French CEO, Board Member
- Steven S. Williamson CEO, Board Member
- Derrick Sung CFO, COO
- Mehul Joshi CFO
- David Lehman General Counsel
- Alissa Hsu Lynch Board Member
- Tiffany Sullivan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Pulmonx Corp (LUNG) | Chief Commercial Officer | $430,000 | $1,957,816 |
| 2022 | Pulmonx Corp (LUNG) | Chief Commercial Officer | $417,000 | $2,193,063 |
| 2021 | Pulmonx Corp (LUNG) | Chief Commercial Officer | $380,000 | $2,032,914 |
| 2020 | Pulmonx Corp (LUNG) | Chief Commercial Officer | $314,718 | $817,881 |
| 2019 | Pulmonx Corp (LUNG) | Chief Commercial Officer | $272,600 | $473,307 |
Recent activity
No call appearances or filed executive changes recorded yet.